Department of Health:
Positive Test Results for COVID-19 Now at 175
DOH reports 24 positive test results today and all of the new cases are adults, none of whom have required hospitalization. All but one of the new cases are residents of the state, and only one (1) non-resident, who tested positive on Hawai‘i Island. Of the 24 new positive test results reported today, 11 are from the City & County of Honolulu, two (2) from the County of Hawai‘i, four (4) from Maui County and one (1) from the County of Kaua‘i. County of diagnosis or residency is pending in 6 (six) cases. There are 175 presumptive or positive cases to date, with the vast majority being Hawai‘i residents (145) and (20) non-residents. To date, 10 cases have unknown residency. There have been nearly 8,000 laboratory tests conducted for COVID-19 samples. Sentinel testing is still on-going and private clinical laboratories are now testing all samples for flu-related illnesses in addition to COVID-19.
“We need to continue practicing social distancing because it is a way to lower the curve of COVID-19 in Hawai‘i. Everyone needs to take the measures implemented seriously and abide by those requirements”, said Health Director Bruce Anderson.
DOH is continuing to aggressively investigate all cases reported and tracing contacts. Most of these are now being reported through private clinical laboratories. To date, more than 7,500 results have been received from private laboratories and, of these, 159 have been positive for COVID- 19. The balance of those tested and found to be positive (13) were identified through State Laboratory testing before the private clinical laboratories were able to test for COVID-19. The State Laboratory continues to serve as a reference laboratory for Hawai‘i and other Pacific Island jurisdictions.
https://health.hawaii.gov/coronavirusdisease2019/
University of Hawai‘i John A. Burns School of Medicine
Jabsom Researcher & Wuhan Colleagues Find Hypnotics Improves COVID-19 Outcomes
Twenty researchers including JABSOM’s Dr. Youping Deng found beneficial effects of hypnotics on clinical outcoes in the management of COVID-19 patients. The research team, which was co-led by a researcher from the Wuhan University of Science and Technology, reviewed the charts of 323 COVID-19 patients in hospitals from Jan. 8 – Feb. 20, 2020. A quarter of the patients were give a hypnotic drug used to treat insomnia, and 77 of the 82 had better clinical outcomes and were discharged. Of the five who had unfavorable outcomes, only one died.
Denby Fawcett: Why So Few People Are Getting The New Covid Shot
Experts are worried about the lack of interest as people are still suffering from the virus and long Covid. By Denby Fawcett Original article on Civil Beat, November 7, 2023 I keep a card in my [...]
Federal Public Health Emergency (PHE) for COVID-19 ends on May 11, 2023
HONOLULU, HI –The federal Public Health Emergency (PHE) for COVID-19, declared under Section 319 of the Public Health Service Act, will expire at the end of the day on May 11, 2023. As the PHE [...]
Seniors now eligible for additional COVID-19 bivalent booster dose, COVID vaccine recommendations simplified
HONOLULU, HI – The Hawai‘i Department of Health (DOH) supports the latest recommendations announced yesterday by the Centers for Disease Control and Prevention (CDC), allowing an additional dose of the bivalent booster against the virus [...]
Hawai‘i COVID-19 hospitalizations on the rise
HONOLULU, HI – The Hawai‘i Department of Health (DOH) reports a rise in the rate of COVID-19 hospitalizations. The number of total positive COVID-19 hospitalizations has increased over the past week (3/26 – 4/4) from [...]
Wastewater Samples Show Higher COVID Concentrations & New Subvariant
The Hawai‘i State Department of Health’s most recent Wastewater Surveillance Report documents two significant developments about COVID-19 in Hawai‛i. Higher concentrations of the virus that causes COVID-19 The arrival of the XBB.1.5 subvariant Higher concentrations [...]
Bivalent boosters for keiki as young as 6 months
Updated COVID-19 bivalent boosters are now available in all counties for keiki as young as six months of age. The U.S. Food and Drug Administration (FDA) amended the emergency use authorization for the bivalent boosters [...]